The Influence of Duration of Peritoneal Dialysis Therapy on the Outcomes of Initial and Subsequent Peritonitis is Different

Rong Xu,Yuan Chen,Suping Luo,Yanjun Li,Jie Dong

DOI: https://doi.org/10.3747/pdi.2011.00193

2012-01-01

Peritoneal Dialysis International

Abstract:The number of patients with a longer peritoneal dialysis (PD) duration is currently growing because of improved survival rates worldwide. To our knowledge, a longer PD duration is associated with alterations of the peritoneal membrane and peritoneal macrophages (1), potentially decreasing the immune defense against peritonitis. However, the current evidence on this issue is conflicting. Earlier studies have reported that a longer PD duration predicts worse (2,3) or better (4) peritonitis outcomes or has no effect (5,6). Notably, recent studies have indicated that first and subsequent peritonitis episodes represent distinct clinical entities (7,8). First episodes of peritonitis have better outcomes than do subsequent episodes—particularly episodes of recurrent peritonitis (7). We hypothesized that different proportions of first and subsequent peritonitis episodes have possibly led to the paradoxical findings across PD centers in earlier studies. We therefore aimed to determine whether the influence of PD therapy duration on peritonitis outcomes is different for first and subsequent peritonitis episodes.